CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV
Hepatitis B remains a major global public health challenge, with particularly high prevalence in medically disadvantaged western Pacific and African regions. Although clinically available technologies for the qPCR detection of HBV are well established, research on point-of-care testing has not progr...
Main Authors: | Ronghua Ding, Jinzhao Long, Mingzhu Yuan, Xue Zheng, Yue Shen, Yuefei Jin, Haiyan Yang, Hao Li, Shuaiyin Chen, Guangcai Duan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/9/4842 |
Similar Items
-
Application of CRISPR/Cas9 Technology to HBV
by: Guigao Lin, et al.
Published: (2015-11-01) -
CRISPR/Cas System: A Potential Technology for the Prevention and Control of COVID-19 and Emerging Infectious Diseases
by: Ronghua Ding, et al.
Published: (2021-04-01) -
RT-LAMP CRISPR-Cas12/13-Based SARS-CoV-2 Detection Methods
by: Kasturi Selvam, et al.
Published: (2021-09-01) -
Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
by: Hao Li, et al.
Published: (2018-09-01) -
SARS-CoV-2 Direct Detection Without RNA Isolation With Loop-Mediated Isothermal Amplification (LAMP) and CRISPR-Cas12
by: Alfredo Garcia-Venzor, et al.
Published: (2021-02-01)